These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 20356937)
41. Human papillomavirus testing for primary cervical cancer screening. Grce M; Davies P Expert Rev Mol Diagn; 2008 Sep; 8(5):599-605. PubMed ID: 18785808 [TBL] [Abstract][Full Text] [Related]
42. Cost-effectiveness analysis of liquid-based cytology and human papillomavirus testing in cervical cancer screening. Bidus MA; Maxwell GL; Kulasingam S; Rose GS; Elkas JC; Chernofsky M; Myers ER Obstet Gynecol; 2006 May; 107(5):997-1005. PubMed ID: 16648402 [TBL] [Abstract][Full Text] [Related]
43. Use of the HPV MLPA assay in cervical cytology for the prediction of high grade lesions. Litjens RJ; Theelen W; van de Pas Y; Ossel J; Reijans M; Simons G; Speel EJ; Slangen BF; Ramaekers FC; Kruitwagen RF; Hopman AH J Med Virol; 2013 Aug; 85(8):1386-93. PubMed ID: 23765775 [TBL] [Abstract][Full Text] [Related]
45. Alternative technologies in cervical cancer screening: a randomised evaluation trial. Anttila A; Hakama M; Kotaniemi-Talonen L; Nieminen P BMC Public Health; 2006 Oct; 6():252. PubMed ID: 17042938 [TBL] [Abstract][Full Text] [Related]
46. [Conventional swab versus swab in liquid medium: two techniques with equivalent performance. A review of the literature validates a study by the French Society of Cytology and the ANAES guidelines]. Cartier I J Gynecol Obstet Biol Reprod (Paris); 2006 Jun; 35(4):321-3. PubMed ID: 16940900 [No Abstract] [Full Text] [Related]
47. How Image Enhancement Is Allowing New Chances for Digital-Cytology in Telemedicine and e-Health. Giansanti D Telemed J E Health; 2017 Jul; 23(7):615-617. PubMed ID: 28121496 [No Abstract] [Full Text] [Related]
48. We are minimally invasive diagnosis. Cibas ES J Am Soc Cytopathol; 2021; 10(2):113-114. PubMed ID: 33478928 [No Abstract] [Full Text] [Related]
49. In Reply to Roussakow. Datta NR; Stutz E; Gomez S; Bodis S Int J Radiat Oncol Biol Phys; 2021 Feb; 109(2):642-644. PubMed ID: 33422281 [No Abstract] [Full Text] [Related]
50. In Regard to Datta et al. Roussakow S Int J Radiat Oncol Biol Phys; 2021 Feb; 109(2):641-642. PubMed ID: 33422279 [No Abstract] [Full Text] [Related]
51. Has screening mammography become obsolete? Costanza ME Curr Oncol; 2015 Oct; 22(5):e328-31. PubMed ID: 26628871 [No Abstract] [Full Text] [Related]
52. Physician attitudes toward dissemination of optical spectroscopy devices for cervical cancer control: an industrial-academic collaborative study. Shinn E; Qazi U; Gera S; Brodovsky J; Simpson J; Follen M; Basen-Engquist K; Macaulay C Gend Med; 2012 Feb; 9(1 Suppl):S67-77; quiz 77.e1-6. PubMed ID: 22340642 [TBL] [Abstract][Full Text] [Related]
53. What Role Should Cytology Play in Cervical Cancer Screening? Perkins RB; Austin RM; Zhao C; Saslow D; Massad LS J Low Genit Tract Dis; 2019 Jul; 23(3):205-209. PubMed ID: 31135652 [No Abstract] [Full Text] [Related]
54. Cervical cancer biopsy reporting: a review. Reyes MC; Cooper K Indian J Pathol Microbiol; 2014; 57(3):364-8. PubMed ID: 25118724 [TBL] [Abstract][Full Text] [Related]
55. Has cytology become obsolete as a primary test in screening for cervical cancer? Sasieni P J Med Screen; 2010; 17(1):2-3. PubMed ID: 20356937 [No Abstract] [Full Text] [Related]
56. Has cytology become obsolete as a primary test in screening for cervical cancer? Rebolj M; Lynge E J Med Screen; 2010; 17(1):1-2. PubMed ID: 20356936 [No Abstract] [Full Text] [Related]
57. Cervical cytology screening in HIV-positive women: do samples from genitourinary medicine departments have high inadequacy rates? Sundaram SS; Vijeratnam D; Patel R; Samraj S Int J STD AIDS; 2012 Mar; 23(3):227. PubMed ID: 22581887 [No Abstract] [Full Text] [Related]